» Articles » PMID: 22858896

Familial Aggregation of Malignant Mesothelioma in Former Workers and Residents of Wittenoom, Western Australia

Overview
Journal Int J Cancer
Specialty Oncology
Date 2012 Aug 4
PMID 22858896
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Clustering of cases of malignant mesothelioma within families has often been observed, but disentangling genetic and exposure effects has not been done. Former workers and residents exposed to crocidolite at Wittenoom, Western Australia, where many families shared exposure to asbestos, have had high rates of mesothelioma. Our study aimed to estimate the additional risk of mesothelioma in relatives, after allowance for common exposure to crocidolite. More than 11,000 former asbestos workers and residents from Wittenoom have been followed up in cancer and death registries. Levels of exposure for all members of the Wittenoom cohorts have been estimated previously. Relationships between family members of all mesothelioma cases were established from questionnaires, birth and death certificates. Expected numbers of cases of mesothelioma were estimated by fitting a Weibull survival model to all data, based on time from first asbestos exposure, duration and intensity of exposure and age. For each family group, the earliest case was considered the index case. Predicted risk was estimated for each subject from the time of diagnosis of the index case. Familial risk ratios were estimated by dividing observed cases by the sum of risks of all same degree relatives of index cases. There were 369 family groups with at least one case of mesothelioma and a further 25 cases of mesothelioma among relatives in the same families, with 12.9 expected. The risk ratio for blood relatives was 1.9 (95% confidence interval [CI] = 1.3-2.9, p = 0.002). These findings suggest an important, but not large, genetic component in mesothelioma, similar to many other cancers.

Citing Articles

The role of single nucleotide polymorphisms related to iron homeostasis in mesothelioma susceptibility after asbestos exposure: a genetic study on autoptic samples.

Grignani P, Visona S, Fronda M, Borrelli P, Monti M, Bertoglio B Front Public Health. 2023; 11:1236558.

PMID: 37942251 PMC: 10628177. DOI: 10.3389/fpubh.2023.1236558.


GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.

Luna J, Bobo A, Cabrera-Rodriguez J, Pagola M, Martin-Martin M, Ruiz M World J Clin Oncol. 2021; 12(8):581-608.

PMID: 34513595 PMC: 8394157. DOI: 10.5306/wjco.v12.i8.581.


Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma.

Brims F Cancers (Basel). 2021; 13(16).

PMID: 34439349 PMC: 8391310. DOI: 10.3390/cancers13164194.


Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017.

Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J JAMA Netw Open. 2021; 4(8):e2120360.

PMID: 34379126 PMC: 8358735. DOI: 10.1001/jamanetworkopen.2021.20360.


Asbestos in High-Risk Communities: Public Health Implications.

Emmett E Int J Environ Res Public Health. 2021; 18(4).

PMID: 33562413 PMC: 7915393. DOI: 10.3390/ijerph18041579.